Filing Flows › Embecta (EMBC) › Q2 FY26
Embecta (EMBC) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed May 5, 2026
Embecta (EMBC) reported revenue of $222M for the second quarter fiscal 2026 (Q2 FY26), -14% from a year earlier and -15% from the quarter before. Operating margin was 15.8%, net loss $4.1M (1.8% of revenue).
Embecta, Q2 FY26: revenue $222M (-14% year over year), operating margin 15.8%, net loss $4.1M, operating cash flow $31.1M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $222M | -15% | -14% |
| Operating profit | $35.0M | -58% | -44% |
| Net earnings | −$4.1M | -109% | -117% |
| Operating cash flow | $31.1M | +81% | -2% |
| Free cash flow | $30.6M | — | -3% |
What changed
Revenue was $221.8M in Q2 FY26, down 14% year over year and down 15% from the previous quarter. Pen Needles was the largest line at 70% of revenue. Pen Needles lost $33.6M year over year (down 18%), 90% of the total change.
Gross margin was 57.6%, down 5.7 points from Q2 FY25. Operating profit was $35.0M, a 15.8% margin (down 8.5 points year over year). Operating expenses fell 8% while revenue fell 14%. The quarter ended with a net loss of $4.1M, after a profit of $44.1M the previous quarter. Net interest and other expense of $25.5M was the main reason.
Operating cash flow was $31.1M (down 2% year over year). Non-cash charges added back $10.2M of depreciation and amortization and $5.7M of share-based compensation. Working capital and other items added $19.3M. After capital expenditures ($500K), free cash flow as the company reports it was $30.6M.
Questions
What was Embecta's revenue in the second quarter fiscal 2026?
Embecta (EMBC) reported revenue of $222M for the second quarter fiscal 2026 (Q2 FY26), -14% from a year earlier and -15% from the quarter before.
Was Embecta profitable in the second quarter fiscal 2026?
Operating profit was $35.0M (15.8% of revenue) and net loss $4.1M.
Source: Embecta 10-Q on SEC EDGAR.